Daxor Corporation (DXR)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $48.78M
Last updated: Nov 17, 2026 at 4:10 PM ET
Daxor Corporation (DXR) Stock Chart
Daxor (DXR) has a latest price of $8.05 on Nov 17, 2026. Its price fell 38.1% over the past 12 months. The month-end price rose 13.3% over the 10 years through Oct 2026, a compound annual rate of 1.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $19.27 in Feb 2019 and its lowest $3.60 in Feb 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DXR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DXR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 21.8%, and over 6 months it fell 29.1%. The month-end price rose 15.1% over the 3 years through Oct 2026, a compound annual rate of 4.8%.
| Period | Change |
|---|---|
| 1 month | -18.2% |
| 3 months | -21.8% |
| 6 months | -29.1% |
| 12 months | -38.1% |
| 12 months, with dividends | -38.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +15.1% | +4.8% |
| 5 years | -14.9% | -3.2% |
| 10 years | +13.3% | +1.3% |
Price by Year
Its best calendar year was 2025, when the price rose 91.8%, and its weakest was 2017, when it fell 44.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.20 | -37.6% |
| 2025 | $14.75 | +91.8% |
| 2024 | $7.69 | -19.9% |
| 2023 | $9.60 | +4.8% |
| 2022 | $9.16 | -18.8% |
| 2021 | $11.29 | -9.7% |
| 2020 | $12.50 | +33.0% |
| 2019 | $9.40 | +14.6% |
| 2018 | $8.20 | +79.3% |
| 2017 | $4.57 | -44.5% |
Trading Range
The price is 19.7% below its 50-day average of $10.02 and 23.0% below its 200-day average of $10.45.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.05 | |
| 50-day average | $10.02 | -19.7% |
| 200-day average | $10.45 | -23.0% |
Price Risk
Over 3 years, its largest fall from a peak was 45.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.27 |
| Largest fall, 1 year | -45.4% |
| Largest fall, 3 years | -45.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DXR
What is DXR's 1-year price change?
Daxor's price fell 38.1% over the past 12 months. With dividends included, the 12-month total return was -38.1%.
What is DXR's 5-year price change?
Daxor's month-end price fell 14.9% over the 5 years through Oct 2026, a compound annual decline of 3.2%. These figures leave out dividends.
What is DXR's beta?
Daxor's 1-year beta against the S&P 500 is 0.27, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 45.4%.
Is the DXR chart free?
Yes. Advanced Charting for DXR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DXR pages: Overview, Charting, Financials, Government Contracts